Cerus Corporation
CERS
#7226
Rank
A$0.73 B
Marketcap
A$3.68
Share price
-0.77%
Change (1 day)
63.35%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.94 Million, an increase over its 2023 earnings that were of -A$41.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-32.07%
2024 -A$16.94 Million-58.95%
2023 -A$41.26 Million-20.74%
2022 -A$52.06 Million-25.7%
2021 -A$70.07 Million-11.99%
2020 -A$79.61 Million-14%
2019 -A$92.57 Million21.73%
2018 -A$76.04 Million-0.65%
2017 -A$76.54 Million-10.96%
2016 -A$85.97 Million4.24%
2015 -A$82.47 Million50.99%
2014 -A$54.62 Million-10.08%
2013 -A$60.75 Million184.13%
2012 -A$21.38 Million-7.91%
2011 -A$23.22 Million
2009 -A$32.79 Million-24.69%
2008 -A$43.54 Million-25.2%
2007 -A$58.2 Million330.54%
2006 -A$13.52 Million1.49%
2005 -A$13.32 Million-61.02%
2004 -A$34.18 Million
2002 -A$84.53 Million10.02%
2001 -A$76.83 Million34.25%
2000 -A$57.23 Million61.02%
1999 -A$35.55 Million-18.81%
1998 -A$43.78 Million93.08%
1997 -A$22.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.33 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.84 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.35 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.54 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA